LEXX
Lexaria Bioscience Corp.
$0.53
-0.03 (-5.36%)
At close · Jul 7
Market Cap
$13.14M
Shares
24,787,446
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$705.92K
+52%
FY2025
Net Income
-$11.9M
-105.4%
FY2025
Gross Margin
99.61%
+0.6pp
FY2025
Operating Margin
-1683.01%
-443.8pp
FY2025
Diluted EPS
-$0.66
-40.4%
FY2025
Operating Cash Flow
-$10.45M
-110.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $368K | $705.92K | $464.28K | $226.21K | $255.4K | $722.74K | $314.79K | $222.61K | $433.29K | $63.64K | $40.72K | — | — | — | — | — | |
| — | — | $14.31K | $43.19K | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | $43.19K | $0 | — | — | — | — | — | — | — | — | — | — | — | |
| $0 | $2720 | $4822 | $31.5K | $71.84K | $175.35K | $99.38K | $22.89K | $25.19K | $29.75K | $45.62K | $29.88K | $0 | $795.2K | $783.27K | $667.86K | |
| $368K | $703.2K | $459.46K | $194.71K | $183.56K | $547.39K | $215.42K | $199.72K | $408.1K | $33.89K | -$4897 | -$15.18K | $0 | $302.25K | $574.49K | $465.91K | |
| — | 99.61% | 98.96% | 86.07% | 71.87% | 75.74% | 68.43% | 89.72% | 94.19% | 53.25% | -12.03% | — | — | — | — | — | |
| $5.75M | $8.24M | $2.36M | $3.67M | $1.84M | $1.26M | $387.07K | $555.73K | $492.86K | $54.19K | $9024 | $146.47K | $0 | — | — | — | |
| $4.09M | $4.35M | $3.85M | $3.06M | $4.96M | $4.97M | $3.98M | $297.21K | $217.66K | $129.73K | $133.68K | $18.83K | $11.63K | $6755 | $2966 | $5181 | |
| — | $36.6K | — | — | — | $6870 | $6772 | $4393 | $1688 | $869 | — | — | — | — | — | — | |
| — | $51.23K | $42.45K | $145.4K | $102.72K | $111.72K | — | — | — | — | — | — | — | — | — | — | |
| $9.83M | $12.58M | $6.21M | $6.73M | $6.8M | $6.23M | $4.36M | $4.36M | $7.02M | $1.96M | $1.27M | $1.97M | $1.56M | $645.8K | $826K | $1M | |
| -$9.46M | -$11.88M | -$5.75M | -$6.53M | -$6.62M | -$5.69M | — | — | — | — | -$1.28M | -$1.98M | -$1.56M | — | — | — | |
| — | -1683.01% | -1239.16% | -2888.5% | -2591.67% | -786.85% | — | — | — | — | -3136.82% | — | — | — | — | — | |
| — | -$11.83M | -$5.71M | -$6.39M | -$6.52M | -$5.58M | — | — | — | — | — | — | — | — | — | — | |
| $1125 | — | — | — | — | — | — | — | — | $6015 | $2250 | $31.54K | $165.79K | $267.36K | $237.64K | $223.67K | |
| -$69.13K | -$30.7K | -$55.52K | -$178.5K | -$764.61K | — | — | — | — | — | — | — | — | — | — | — | |
| — | $33.54K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$11.91M | -$5.81M | -$6.71M | -$7.38M | -$4.17M | -$3.99M | -$4.16M | -$6.61M | -$1.93M | -$1.27M | — | -$1.56M | — | — | — | |
| — | — | — | — | $0 | $6093 | $2319 | $17.66K | $0 | $0 | $0 | — | — | — | — | — | |
| -$9.53M | -$11.9M | -$5.8M | -$6.66M | -$7.27M | -$4.03M | -$4.08M | $4.1M | $6.6M | -$1.93M | -$1.28M | -$1.98M | -$1.56M | — | — | -$538.23K | |
| — | -1686% | -1248.25% | -2946.36% | -2846.28% | -557.19% | -1297.56% | 1841.79% | 1523.24% | -3031.89% | -3136.82% | — | — | — | — | — | |
| -$8153 | -$9593 | -$13.31K | -$47.63K | -$114.33K | -$159.14K | -$150.62K | -$58.99K | -$10.34K | -$60.19K | -$62.48K | -$163.85K | $0 | — | — | — | |
| -$7.03M | — | — | — | -$7.27M | -$4.03M | -$3.93M | -$4.1M | -$6.61M | -$1.87M | -$1.21M | -$1.77M | $0 | — | — | — | |
| -$9.47M | -$11.95M | -$5.82M | -$6.66M | — | — | — | — | -$6.62M | -$1.93M | -$1.28M | -$1.77M | -$343.55K | -$343.55K | -$251.51K | -$538.23K | |
| USD/shares | — | -$0.66 | -$0.47 | -$1.01 | — | — | — | — | — | — | — | — | — | — | — | -$0.04 |
| shares | — | — | — | — | — | 4.39M | 2.77M | 77.79M | 70.96M | 58.77M | 43.84M | 39.7M | 23.37M | 16.43M | 16.43M | — |
| shares | — | 18M | 12.38M | 6.61M | — | 4.39M | 2.77M | 77.79M | 70.96M | 58.77M | 43.84M | 39.7M | 23.37M | 16.43M | 16.43M | 14.18M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
|---|---|---|---|---|---|---|
| Intellectual Property Licensing | $696,000 | $457,990 | $146,800 | $54,560 | $334,974 | — |
| Consolidated Total | — | — | — | — | $722,738 | $384,543 |
| Intellectual Property Licensing | — | — | — | — | $334,974 | $232,909 |
| Rand D | — | — | — | $54,800 | — | — |
| Corporate | — | $0 | $0 | $32,599 | $90,485 | $0 |
By Product & Service (USD)
| Component | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
|---|---|---|---|---|---|---|
| IP Licensing | $696,000 | $457,990 | — | — | — | — |
| B Two B | $9,923 | $5,388 | — | — | — | — |
| Other Revenue | $0 | $900 | — | — | — | — |
| B2 B | — | — | — | — | $297,279 | $151,634 |
| R and D | — | $900 | $35,241 | $54,800 | — | — |
| Product | — | — | — | $113,438 | $297,279 | — |